Key statistics
On Monday, Lumos Pharma Inc (LUMO:NMQ) closed at 3.76, -17.36% below its 52-week high of 4.55, set on Nov 08, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 3.91 |
---|---|
High | 3.99 |
Low | 3.76 |
Bid | 3.65 |
Offer | 4.20 |
Previous close | 3.93 |
Average volume | 30.85k |
---|---|
Shares outstanding | 8.12m |
Free float | 5.30m |
P/E (TTM) | -- |
Market cap | 31.93m USD |
EPS (TTM) | -4.43 USD |
Data delayed at least 15 minutes, as of Sep 23 2024 21:00 BST.
More ▼
- Lumos Pharma Announces Abstract Accepted for Presentation at September Medical Meeting, SLEP 2024
- Lumos Pharma to Participate in H.C. Wainwright 26th Annual Global Investment Conference
- Lumos Pharma Reports Second Quarter 2024 Financial Results and Provides Clinical Development Update
- Lumos Pharma to Report Second Quarter 2024 Financial Results and Provide Clinical Update on August 1, 2024
- Lumos Pharma Announces New Analyses of Phase 2 OraGrowtH212 Trial Presented at ENDO 2024
- Lumos Pharma Announces Abstracts Accepted for Presentation at ENDO 2024
- Lumos Pharma Announces Positive End-of-Phase 2 Meeting with FDA and Reports First Quarter 2024 Financial Results
- Lumos Pharma to Report First Quarter 2024 Financial Results and Provide Clinical Update on May 15, 2024
- Lumos Pharma Announces Abstracts Accepted for Presentation at Upcoming Medical Meetings
- Lumos Pharma Announces that the USPTO Has Granted Patent Protection for Novel Formulation of LUM-201, Extending Exclusivity to 2042
More ▼